Cargando…
Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
BACKGROUND: Since the coronavirus disease 2019 (COVID-19) has risen, several risk factors have been identified, predicting a worse outcome. It has been speculated that patients with Multiple sclerosis (MS) have an increased risk for a severe course of COVID-19 due to a suspected higher vulnerability...
Autores principales: | Richter, Daniel, Faissner, Simon, Bartig, Dirk, Tönges, Lars, Hellwig, Kerstin, Ayzenberg, Ilya, Krogias, Christos, Gold, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364944/ https://www.ncbi.nlm.nih.gov/pubmed/34399858 http://dx.doi.org/10.1186/s42466-021-00143-y |
Ejemplares similares
-
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
por: Richter, Daniel, et al.
Publicado: (2021) -
Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021
por: Richter, Daniel, et al.
Publicado: (2023) -
Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021) -
Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021) -
COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2022)